Viral surface glycoproteins, Gp120 and Gp41, as potential drug targets against HIV-1: Brief overview one quarter of a century past the approval of zidovudine, the first anti-retroviral drug (vol 46, pg 979, 2011)

subject category

Pharmacology & Pharmacy

authors

Teixeira, C; Gomes, JRB; Gomes, P; Maurel, F; Barbault, F

our authors

Share this project:

Related Publications

We use cookies for marketing activities and to offer you a better experience. By clicking “Accept Cookies” you agree with our cookie policy. Read about how we use cookies by clicking "Privacy and Cookie Policy".